Compare AXIL & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AXIL | CCEL |
|---|---|---|
| Founded | 2015 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | Managed Health Care |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.4M | 32.7M |
| IPO Year | N/A | 1997 |
| Metric | AXIL | CCEL |
|---|---|---|
| Price | $8.14 | $3.80 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 3.5K |
| Earning Date | 01-07-2026 | 10-15-2025 |
| Dividend Yield | N/A | ★ 10.34% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.15 | N/A |
| Revenue | $27,262,468.00 | ★ $31,747,500.00 |
| Revenue This Year | N/A | $0.30 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $59.54 | ★ N/A |
| Revenue Growth | ★ 0.07 | N/A |
| 52 Week Low | $3.75 | $3.57 |
| 52 Week High | $10.75 | $8.79 |
| Indicator | AXIL | CCEL |
|---|---|---|
| Relative Strength Index (RSI) | 72.31 | 42.58 |
| Support Level | $4.93 | $3.81 |
| Resistance Level | $9.11 | $4.38 |
| Average True Range (ATR) | 0.60 | 0.27 |
| MACD | 0.41 | -0.01 |
| Stochastic Oscillator | 66.60 | 28.05 |
AXIL Brands Inc is a company which is is a manufacturer and marketer of premium hearing enhancement and protection products, including ear plugs, earmuffs, and ear buds, and outdoor speakers, under the AXIL brand. AXIL delivers top hearing enhancement, protection, & audio devices. From ultra comfortable fitting processes, to stereo quality sound performance, to reliable & durable engineering. The company operates two operating segments: hearing enhancement and protection, and hair and skin care.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.